Eduardo Teixeiras

The Jackson Laboratory (JAX) is a leading nonprofit biomedical research institution advancing precision medicine through genetics and genomics. As Vice President of Global Operations for JMCRS, I lead a multi-site manufacturing and preclinical operations network supporting research and commercial activities across North America and global markets. My role focuses on strengthening operational performance, scaling capabilities, and aligning scientific innovation with disciplined business execution. Key contributions include: • Leading end-to-end operations across multiple manufacturing and laboratory sites, overseeing production, supply chain, and operational strategy supporting revenue-generating activities. • Driving operational transformation initiatives focused on process optimization, cost efficiency, and operational excellence through Lean methodologies and continuous improvement. • Building and scaling the supply chain function to strengthen planning, logistics, and operational coordination, improving service levels and organizational agility. • Strengthening safety and operational culture by implementing a company-wide safety mindset and reinforcing leadership accountability across operations. • Partnering with executive leadership on strategic initiatives supporting long-term operational planning, capacity expansion, and organizational performance improvement.

Haleon is a global consumer health company with leading brands including Sensodyne, Panadol, and Centrum, operating across more than 170 markets. As Site Director of the Oak Hill manufacturing facility, I led end-to-end OTC drug manufacturing operations supporting the North America business unit, with exports to Canada, Latin America, and Asia. The role included full operational leadership of the site, including manufacturing, quality, supply chain, and financial performance. Key contributions include: • Led a cultural transformation across the site, strengthening compliance, employee engagement, operational discipline, and customer service performance. • Directed manufacturing operations and site strategy, aligning production, supply chain planning, and commercial priorities to support regional market demand. • Owned full site P&L performance, managing operational budgets and capital investments to support operational efficiency and long-term capacity needs. • Strengthened supply chain execution through robust S&OP and cross-functional planning, improving alignment between manufacturing operations and business demand. • Successfully led the site through FDA inspection with zero observations, representing a significant improvement compared to previous regulatory outcomes.

Relocated to the United States to lead one of GSK’s largest OTC manufacturing sites in North America, with full accountability for end-to-end operations, including manufacturing, engineering, supply chain, quality, and operational performance. Key contributions: • Led site-wide operational transformation, improving productivity, increasing OEE, and reducing cost of goods through disciplined execution and continuous improvement. • Strengthened compliance and operational discipline, reinforcing a high-performance culture focused on safety, quality, and reliability. • Optimized end-to-end manufacturing and supply chain processes, improving delivery performance, service levels, inventory management, and overall operational efficiency.

Led one of GSK’s key manufacturing sites in Latin America, with responsibility for site performance, transformation, and regional supply. Key contributions: • Led site transformation and restructuring, significantly improving productivity and reducing cost per unit while maintaining high-quality standards. • Played a key leadership role in the GSK Consumer Healthcare separation, supporting operational readiness and ensuring continuity during the transition. • Led SAP implementation, strengthening operational planning, performance visibility, and alignment with global systems and standards. • Expanded OTC manufacturing capabilities and regional footprint, supporting product launches and growth across Latin American markets. • Strengthened collaboration with commercial teams, aligning portfolio strategy, cost structures, and market demand to drive regional performance.

Led multi-format manufacturing operations, including solids, semi-solids, liquids, and medical devices. Key contributions: • Transformed production value streams, improving efficiency, quality, and operational performance across multiple product categories. • Drove significant OEE and productivity improvements through team restructuring and continuous improvement initiatives. • Reduced quality deviations by 65%, significantly improving product availability and service levels. • Achieved ~98.5% OTIF delivery performance, strengthening customer service and operational reliability.

Led engineering, maintenance, and capital investment programs supporting site performance and compliance. Key contributions: • Implemented TPM across maintenance operations, reducing breakdowns by ~65% and significantly improving equipment reliability (MTBF). • Led capital projects and site remediation efforts, strengthening GMP compliance, sustainability, and operational capability. • Enhanced project execution capability, aligning engineering resources with strategic site priorities.

Led engineering, maintenance, and capital investment strategy for a large-scale manufacturing site, supporting operational performance, reliability, and long-term capability development. Key contributions: • Led capital investment and maintenance strategy for a large manufacturing site, strengthening asset reliability and operational performance. • Implemented Total Productive Maintenance (TPM), improving preventive maintenance, equipment efficiency, and overall reliability. • Developed engineering and technical capabilities across teams, enhancing workforce engagement, skills, and retention.

Led global engineering and automation projects supporting multiple Nestlé business units, including coffee, cocoa, malt beverages, and infant nutrition. Key contributions: • Led a multicultural engineering team delivering global projects, supporting innovation and process optimization across multiple product categories. • Managed automation and MES initiatives, enabling standardization and operational improvements across manufacturing sites worldwide. • Provided technical leadership and project execution support to global factories, strengthening engineering capabilities and process performance.

Coordinated technical support for global process engineering, electrical, and automation projects across Nestlé manufacturing sites. Key contributions: • Led coordination of engineering support for global capital projects, ensuring effective execution of electrical and automation initiatives. • Contributed to the development and global rollout of new coffee aroma technology, successfully implemented across multiple manufacturing sites.

• Supported process control, automation, and engineering initiatives across manufacturing operations.

Led cross-functional MES projects within a regulated manufacturing environment, supporting operational improvements and execution of strategic initiatives. • Managed end-to-end project delivery, coordinating cross-functional teams across engineering, operations, and quality. • Supported process improvements and operational initiatives, ensuring alignment with regulatory and business requirements.

Built a strong technical foundation in automation, process control, and manufacturing systems within large-scale food production environments across Brazil and Switzerland. • Developed and implemented automation and process control solutions, improving operational efficiency and equipment reliability. • Supported manufacturing operations and capital projects across multiple production lines globally, contributing to performance improvement and process standardization. • Established core expertise in industrial operations and manufacturing systems, forming the foundation for future leadership roles.

Fundamentals of Biomanufacturing provides a general overview of the production of drug substances used in drug products that help prevent or treat human diseases.